Published in Neurosurg Clin N Am on January 01, 2006
Genomic Landscape of Intramedullary Astrocytoma (GIMA) | NCT04211974
Spinal cord tumours: advances in genetics and their implications for treatment. Nat Rev Neurol (2013) 0.88
An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg (2011) 6.32
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol (2008) 2.71
Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg (2010) 2.42
Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg (2010) 2.19
Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg (2013) 2.16
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15
Complications of lumboperitoneal shunts. Neurosurgery (2007) 2.07
Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol (2012) 2.04
Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res (2013) 1.86
Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg (2010) 1.74
Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg (2010) 1.72
The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg (2010) 1.67
Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg (2010) 1.67
Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg (2011) 1.67
Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg (2008) 1.66
Cancer and the complement cascade. Mol Cancer Res (2010) 1.64
Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg (2012) 1.64
The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci (2009) 1.62
Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg (2009) 1.59
Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr (2012) 1.57
Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss. J Neurosurg (2010) 1.55
Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg (2013) 1.55
Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg (2011) 1.54
Extent of resection and the long-term durability of vestibular schwannoma surgery. J Neurosurg (2011) 1.53
Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article. J Neurosurg (2010) 1.53
Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res (2006) 1.52
Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review. J Neurosurg Spine (2013) 1.51
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg (2015) 1.48
Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma. J Neurosurg (2010) 1.48
A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg (2010) 1.46
What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg (2014) 1.44
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol (2009) 1.43
Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg (2010) 1.38
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol (2012) 1.38
Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer (2011) 1.35
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J Immunother (2009) 1.33
The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus (2011) 1.33
Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. J Neurosurg (2009) 1.32
Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg (2010) 1.28
Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology (2010) 1.28
CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci (2010) 1.26
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol (2009) 1.25
Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg (2005) 1.25
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol (2013) 1.25
Changes in transcranial motor evoked potentials during intramedullary spinal cord tumor resection correlate with postoperative motor function. Neurosurgery (2005) 1.24
Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein. Clin Cancer Res (2012) 1.15
The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res (2010) 1.14
Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery (2012) 1.13
A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci (2009) 1.13
A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg (2010) 1.11
A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg (2010) 1.07
Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol (2009) 1.06
Cranial chondrosarcoma and recurrence. Skull Base (2010) 1.06
Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus (2010) 1.05
Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy. Neurosurg Clin N Am (2010) 1.04
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol (2014) 1.04
Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer (2010) 1.03
Embolization of skull base meningiomas and feeding vessels arising from the internal carotid circulation. Neurosurgery (2011) 1.03
Endoscopic reconstruction of skull base defects with the nasal septal flap. Skull Base (2008) 1.03
Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients. Cancer (2010) 1.02
mTOR-independent translational control of the extrinsic cell death pathway by RalA. Mol Cell Biol (2006) 1.01
Gross total resection improves overall survival in children with choroid plexus carcinoma. J Neurooncol (2013) 0.99
Radiosurgery of glomus jugulare tumors: a meta-analysis. Int J Radiat Oncol Biol Phys (2011) 0.99
Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. J Clin Neurosci (2009) 0.98
Current management of choroid plexus carcinomas. Neurosurg Rev (2013) 0.98
The long-term postsurgical prognosis of patients with pineoblastoma. Cancer (2011) 0.97
Pathologic and epidemiologic findings of intramedullary spinal cord tumors. Neurosurg Clin N Am (2006) 0.97
Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol (2010) 0.97
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. J Clin Invest (2014) 0.97
The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. J Neurosurg (2010) 0.96
Choroid plexus papillomas: advances in molecular biology and understanding of tumorigenesis. Neuro Oncol (2012) 0.96
Tuberculoma of the central nervous system. J Clin Neurosci (2013) 0.96
Impact of bevacizumab chemotherapy on craniotomy wound healing. J Neurosurg (2010) 0.96
Systematic review of protein biomarkers of invasive behavior in glioblastoma. Mol Neurobiol (2013) 0.95
Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro. Clin Immunol (2002) 0.95
Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas. Neurosurgery (2006) 0.95
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients. J Neurosurg (2010) 0.95
Fluctuating response of a cystic vestibular schwannoma to radiosurgery: case report. Neurosurgery (2008) 0.94
Immunological considerations of modern animal models of malignant primary brain tumors. J Transl Med (2009) 0.93
Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas. Neurosurgery (2007) 0.93
Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics. J Neurosurg (2009) 0.93
Clinical characteristics and diagnostic imaging of epidermoid tumors. J Clin Neurosci (2011) 0.92
Management of recurrent intracranial hemangiopericytoma. J Clin Neurosci (2011) 0.92
A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas. J Neurosurg Pediatr (2013) 0.92
A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Childs Nerv Syst (2012) 0.92
Immunocompetent murine models for the study of glioblastoma immunotherapy. J Transl Med (2014) 0.92
A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res (2009) 0.91
Radiosurgery for glomus jugulare: history and recent progress. Neurosurg Focus (2009) 0.91
Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion. Neuroreport (2009) 0.90
The molecular biology and novel treatments of vestibular schwannomas. J Neurosurg (2011) 0.90
Prognosis by tumor location in adults with spinal ependymomas. J Neurosurg Spine (2013) 0.90
A comprehensive analysis of intracranial chordoma and survival: a systematic review. Br J Neurosurg (2011) 0.90
Clinical and surgical considerations for cerebellopontine angle meningiomas. J Clin Neurosci (2011) 0.90
Modified paramedian transpedicular approach and spinal reconstruction for intradural tumors of the cervical and cervicothoracic spine: clinical experience. Spine (Phila Pa 1976) (2007) 0.89
Preservation of facial nerve function after resection of vestibular schwannoma. Br J Neurosurg (2010) 0.89
Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci (2011) 0.89
Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res (2010) 0.89
Vaccine therapies for patients with glioblastoma. J Neurooncol (2014) 0.88
Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells. PLoS One (2012) 0.87